All — ST PHARM

Science & Technology
- Business Overview
- CDMO
- CRO
  - AnaPath Research & Service
- R&D
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

All

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

ST PHARM's Public Release

ST PHARM NewsST Pharm to Present Basroparib (STP1002) at ESMO Congress 2024Sep 6, 2024

ST PHARM NewsST Pharm Banwol Campus Awarded EcoVadis 'Gold' MedalSep 6, 2024

ST PHARM NewsST Pharm, honored with two awards at the ‘Korea Biopharma Excellence Awards 2024’Aug 19, 2024

ST PHARM NewsST PHARM's Participation in 2024 DCAT Week Highlights Innovation in Pharmaceutical SectorMar 20, 2024

ST PHARM News[Notice] RNA Innovation Symposium Corea/Korea 2024 (RISC 2024)Feb 26, 2024

ST PHARM NewsST PHARM, Pirmitegravir (STP0404), HIV: Three trials to watch in 2024Jan 15, 2024

ST PHARM News[ST Pharm Webinar Series] mRNA TechnologiesDec 14, 2023

ST PHARM News[Tides Europe 2023] Exploring Excellence in Oligonucleotide CDMO services at ST PharmDec 14, 2023

ST PHARM News'100-Day Expedite Strategy', Preparedness and Proactive Measures for Future PandemicNov 21, 2023

ST PHARM News'To Become a Global Korean CDMO' - 2023 Economic Daily Pharmaceutical Bio ForumNov 21, 2023

ST PHARM NewsInvesting in mRNA platforms to create CDMO-biotech partnership opportunitiesNov 13, 2023

ST PHARM NewsVisit of the International Vaccine Institute (IVI) Board of Trustees at ST PharmNov 9, 2023

ST PHARM News[ST Pharm Leaflet] Small MoleculeOct 31, 2023

1of5